Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0389 Transporter Info | ||||
Gene Name | SLC4A9 | ||||
Transporter Name | Anion exchange protein 4 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Bladder cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg02481956) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.45E+00 | Statistic Test | p-value: 5.24E-13; Z-score: -1.28E+01 | ||
Methylation in Case |
2.70E-01 (Median) | Methylation in Control | 6.61E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in bladder cancer | [ 1 ] | |||
Location |
TSS200 (cg07493760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 3.31E-06; Z-score: -4.65E+00 | ||
Methylation in Case |
4.18E-01 (Median) | Methylation in Control | 5.32E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in bladder cancer | [ 1 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.16E+00 | Statistic Test | p-value: 6.80E-14; Z-score: -1.48E+01 | ||
Methylation in Case |
8.96E-02 (Median) | Methylation in Control | 1.94E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in bladder cancer | [ 1 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.40E+00 | Statistic Test | p-value: 4.73E-12; Z-score: -1.10E+01 | ||
Methylation in Case |
2.44E-01 (Median) | Methylation in Control | 5.86E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in bladder cancer | [ 1 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.96E+00 | Statistic Test | p-value: 6.57E-05; Z-score: -3.73E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 3.05E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC4A9 in bladder cancer | [ 1 ] | |||
Location |
3'UTR (cg14564815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 1.22E-04; Z-score: -4.79E+00 | ||
Methylation in Case |
2.17E-01 (Median) | Methylation in Control | 2.62E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg02481956) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.31E-04; Z-score: -1.06E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 7.46E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg07493760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.30E-03; Z-score: -5.47E-01 | ||
Methylation in Case |
6.02E-01 (Median) | Methylation in Control | 6.20E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in breast cancer | [ 2 ] | |||
Location |
1stExon (cg08457872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.28E-10; Z-score: -2.11E+00 | ||
Methylation in Case |
7.24E-01 (Median) | Methylation in Control | 7.85E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in breast cancer | [ 2 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.54E+00 | Statistic Test | p-value: 9.33E-10; Z-score: -2.16E+00 | ||
Methylation in Case |
1.33E-01 (Median) | Methylation in Control | 2.05E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in breast cancer | [ 2 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.67E+00 | Statistic Test | p-value: 1.76E-09; Z-score: -1.86E+00 | ||
Methylation in Case |
3.33E-01 (Median) | Methylation in Control | 5.58E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC4A9 in breast cancer | [ 2 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.78E-02; Z-score: -2.15E-01 | ||
Methylation in Case |
2.97E-01 (Median) | Methylation in Control | 3.11E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC4A9 in breast cancer | [ 2 ] | |||
Location |
3'UTR (cg14564815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 3.67E-08; Z-score: 2.19E+00 | ||
Methylation in Case |
2.79E-01 (Median) | Methylation in Control | 2.08E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in colon adenocarcinoma | [ 3 ] | |||
Location |
TSS1500 (cg04344565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.41E+00 | Statistic Test | p-value: 5.53E-08; Z-score: 1.66E+00 | ||
Methylation in Case |
5.18E-01 (Median) | Methylation in Control | 3.69E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in colon adenocarcinoma | [ 3 ] | |||
Location |
TSS200 (cg15044957) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.25E+00 | Statistic Test | p-value: 5.85E-05; Z-score: 1.04E+00 | ||
Methylation in Case |
5.87E-01 (Median) | Methylation in Control | 4.68E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in colon adenocarcinoma | [ 3 ] | |||
Location |
3'UTR (cg27024381) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.05E-03; Z-score: -1.20E+00 | ||
Methylation in Case |
5.48E-01 (Median) | Methylation in Control | 5.76E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg02481956) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 9.89E-06; Z-score: -1.44E+00 | ||
Methylation in Case |
6.52E-01 (Median) | Methylation in Control | 7.48E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg03551019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 4.15E-02; Z-score: 3.22E-01 | ||
Methylation in Case |
9.23E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in colorectal cancer | [ 4 ] | |||
Location |
TSS200 (cg07493760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 4.10E-03; Z-score: -6.69E-01 | ||
Methylation in Case |
7.91E-01 (Median) | Methylation in Control | 8.29E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in colorectal cancer | [ 4 ] | |||
Location |
1stExon (cg08457872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.49E-04; Z-score: -1.04E+00 | ||
Methylation in Case |
8.96E-01 (Median) | Methylation in Control | 9.08E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 4.58E-07; Z-score: -1.54E+00 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 6.38E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC4A9 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg18014856) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 3.43E-02; Z-score: 5.28E-01 | ||
Methylation in Case |
7.46E-02 (Median) | Methylation in Control | 6.89E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC4A9 in colorectal cancer | [ 4 ] | |||
Location |
3'UTR (cg14564815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.03E-02; Z-score: 5.44E-01 | ||
Methylation in Case |
4.09E-01 (Median) | Methylation in Control | 3.85E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg09638395) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 4.81E-10; Z-score: -3.97E+00 | ||
Methylation in Case |
7.06E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg06122660) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.33E+00 | Statistic Test | p-value: 9.56E-20; Z-score: 5.21E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 1.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS200 (cg07493760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.37E-04; Z-score: -4.69E-01 | ||
Methylation in Case |
6.81E-01 (Median) | Methylation in Control | 6.96E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
1stExon (cg13958974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.60E+00 | Statistic Test | p-value: 1.58E-19; Z-score: 4.96E+00 | ||
Methylation in Case |
4.70E-01 (Median) | Methylation in Control | 2.94E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
1stExon (cg08457872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 4.56E-05; Z-score: -8.01E-01 | ||
Methylation in Case |
7.81E-01 (Median) | Methylation in Control | 8.01E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg11234429) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.46E+00 | Statistic Test | p-value: 4.43E-17; Z-score: -4.71E+00 | ||
Methylation in Case |
4.16E-01 (Median) | Methylation in Control | 6.09E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 8.15E-07; Z-score: -8.75E-01 | ||
Methylation in Case |
8.92E-02 (Median) | Methylation in Control | 1.06E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.69E-06; Z-score: -1.51E+00 | ||
Methylation in Case |
3.72E-01 (Median) | Methylation in Control | 4.71E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC4A9 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 1.86E-02; Z-score: -9.21E-01 | ||
Methylation in Case |
1.86E-01 (Median) | Methylation in Control | 2.44E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg02481956) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.96E-03; Z-score: 5.12E-01 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 7.84E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in HIV infection | [ 6 ] | |||
Location |
1stExon (cg08457872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.27E-03; Z-score: -1.21E+00 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.68E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in HIV infection | [ 6 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.95E-04; Z-score: 1.10E+00 | ||
Methylation in Case |
4.54E-01 (Median) | Methylation in Control | 3.78E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in HIV infection | [ 6 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 6.37E-04; Z-score: -9.05E-01 | ||
Methylation in Case |
5.59E-01 (Median) | Methylation in Control | 6.25E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in HIV infection | [ 6 ] | |||
Location |
3'UTR (cg14564815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 3.36E-04; Z-score: 9.67E-01 | ||
Methylation in Case |
4.12E-01 (Median) | Methylation in Control | 3.83E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg03551019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 4.38E-02; Z-score: 7.46E-01 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 7.72E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in lung adenocarcinoma | [ 7 ] | |||
Location |
1stExon (cg08457872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.73E-03; Z-score: -1.59E+00 | ||
Methylation in Case |
8.16E-01 (Median) | Methylation in Control | 8.39E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 2.59E-03; Z-score: -1.86E+00 | ||
Methylation in Case |
1.69E-01 (Median) | Methylation in Control | 2.37E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 6.12E-03; Z-score: -1.64E+00 | ||
Methylation in Case |
4.80E-01 (Median) | Methylation in Control | 5.63E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in lung adenocarcinoma | [ 7 ] | |||
Location |
3'UTR (cg14564815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 3.48E-04; Z-score: 2.58E+00 | ||
Methylation in Case |
3.65E-01 (Median) | Methylation in Control | 2.94E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg01470323) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 4.59E-06; Z-score: -1.23E+00 | ||
Methylation in Case |
1.89E-01 (Median) | Methylation in Control | 2.46E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS200 (cg03278965) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 9.50E-05; Z-score: -7.02E-01 | ||
Methylation in Case |
1.08E-01 (Median) | Methylation in Control | 1.24E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
1stExon (cg04711050) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.10E-02; Z-score: -6.45E-01 | ||
Methylation in Case |
7.69E-02 (Median) | Methylation in Control | 8.62E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg00844950) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.54E-02; Z-score: 1.20E-01 | ||
Methylation in Case |
9.30E-02 (Median) | Methylation in Control | 8.91E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg03551019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.31E-05; Z-score: 1.41E+00 | ||
Methylation in Case |
7.75E-01 (Median) | Methylation in Control | 7.20E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg07493760) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 2.77E-09; Z-score: 1.36E+00 | ||
Methylation in Case |
4.43E-01 (Median) | Methylation in Control | 3.63E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in papillary thyroid cancer | [ 9 ] | |||
Location |
1stExon (cg08457872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 4.66E-04; Z-score: 1.08E+00 | ||
Methylation in Case |
7.83E-01 (Median) | Methylation in Control | 7.40E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 4.41E-17; Z-score: -2.07E+00 | ||
Methylation in Case |
4.54E-01 (Median) | Methylation in Control | 6.12E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 3.27E-12; Z-score: -1.82E+00 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 1.56E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in systemic lupus erythematosus | [ 10 ] | |||
Location |
TSS1500 (cg03551019) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 3.45E-02; Z-score: -1.38E-01 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.99E-03; Z-score: 3.81E-01 | ||
Methylation in Case |
4.11E-01 (Median) | Methylation in Control | 3.89E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 6.61E-03; Z-score: -2.95E-01 | ||
Methylation in Case |
1.98E-01 (Median) | Methylation in Control | 2.12E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg18014856) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 7.69E-03; Z-score: -1.68E-01 | ||
Methylation in Case |
5.49E-02 (Median) | Methylation in Control | 5.72E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in systemic lupus erythematosus | [ 10 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.59E-02; Z-score: -1.64E-01 | ||
Methylation in Case |
5.27E-01 (Median) | Methylation in Control | 5.55E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
1stExon (cg08457872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.67E+00 | Statistic Test | p-value: 5.45E-21; Z-score: -3.51E+00 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 7.26E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.68E+00 | Statistic Test | p-value: 2.79E-03; Z-score: -1.04E+00 | ||
Methylation in Case |
2.15E-01 (Median) | Methylation in Control | 3.61E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 4.11E-03; Z-score: 4.61E-01 | ||
Methylation in Case |
8.30E-01 (Median) | Methylation in Control | 7.91E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 5.61E-03; Z-score: 4.50E-01 | ||
Methylation in Case |
8.01E-02 (Median) | Methylation in Control | 7.55E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC4A9 in atypical teratoid rhabdoid tumor | [ 11 ] | |||
Location |
3'UTR (cg14564815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.59E+00 | Statistic Test | p-value: 4.37E-11; Z-score: -2.44E+00 | ||
Methylation in Case |
4.05E-01 (Median) | Methylation in Control | 6.45E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in clear cell renal cell carcinoma | [ 12 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.57E+00 | Statistic Test | p-value: 7.55E-10; Z-score: -4.10E+00 | ||
Methylation in Case |
4.61E-01 (Median) | Methylation in Control | 7.22E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in clear cell renal cell carcinoma | [ 12 ] | |||
Location |
Body (cg08215811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 2.06E-04; Z-score: -1.60E+00 | ||
Methylation in Case |
8.94E-02 (Median) | Methylation in Control | 1.24E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in clear cell renal cell carcinoma | [ 12 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 2.08E-02; Z-score: 8.11E-01 | ||
Methylation in Case |
2.44E-01 (Median) | Methylation in Control | 2.10E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in panic disorder | [ 13 ] | |||
Location |
Body (cg06660015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -8.44E-01 | Statistic Test | p-value: 1.79E-02; Z-score: -4.54E-01 | ||
Methylation in Case |
-2.11E+00 (Median) | Methylation in Control | -1.78E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in panic disorder | [ 13 ] | |||
Location |
Body (cg07521929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.74E+00 | Statistic Test | p-value: 2.03E-02; Z-score: 5.94E-01 | ||
Methylation in Case |
5.86E-01 (Median) | Methylation in Control | 3.37E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC4A9 in prostate cancer | [ 14 ] | |||
Location |
Body (cg09996840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 2.54E-02; Z-score: -2.44E+00 | ||
Methylation in Case |
4.03E-01 (Median) | Methylation in Control | 5.18E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC4A9 in prostate cancer | [ 14 ] | |||
Location |
Body (cg16902190) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 2.96E-02; Z-score: 1.63E+00 | ||
Methylation in Case |
9.07E-01 (Median) | Methylation in Control | 8.39E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC4A9 in prostate cancer | [ 14 ] | |||
Location |
Body (cg09951201) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 3.18E-02; Z-score: 1.64E+00 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 8.41E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC4A9 in prostate cancer | [ 14 ] | |||
Location |
Body (cg15128778) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 4.79E-02; Z-score: 3.34E+00 | ||
Methylation in Case |
8.16E-01 (Median) | Methylation in Control | 7.09E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.